Search
for
Sort by
Research 181–210 of 642
- Integrated Model of Care for Polycystic Ovary Syndrome
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Women’s Health Considerations for Lipid Management
- Polycystic ovary syndrome: a dermatologic approach
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Clinical manifestations of polycystic ovary syndrome
- Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial
- Prevalence Study of Dermatologic Manifestations among Diabetic Patients
- Association of Infant Physical Development and Rapid Growth With Pubertal Onset Among Girls in Rural China
- COVID‐19, androgens, and androgenic alopecia
- Can resistance training improve the symptoms of polycystic ovary syndrome?
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- Skin manifestations after bariatric surgery
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- PCOS and Obesity: Contraception Challenges
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Women’s Health Considerations for Lipid Management
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Evaluation of Sleep Quality, Restless Legs Syndrome, Anxiety and Depression in Polycystic Ovary Syndrome
- ANDROGRAPHOLIDE LOADED TOPICAL NANOCARRIERS FOR MANAGEMENT OF PSORIASIS: A SAFE AND EFFECTIVE APPROACH
- Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
- Debatable Topics in PCOS Patients
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Polycystic Ovary Syndrome: Impact of Lifestyle Modifications Among Overweight and Obese Infertile Women